Literature DB >> 25499407

ICG angiography predicts burn scarring within 48 h of injury in a porcine vertical progression burn model.

Mitchell S Fourman1, Peter McKenna2, Brett T Phillips2, Laurie Crawford2, Filippo Romanelli2, Fubao Lin2, Steve A McClain2, Sami U Khan2, Alexander B Dagum2, Adam J Singer2, Richard A F Clark2.   

Abstract

The current standard of care in determining the need to excise and graft a burn remains with the burn surgeon, whose clinical judgment is often variable. Prior work suggests that minimally invasive perfusion technologies are useful in burn prognostication. Here we test the predictive capabilities of Laser Doppler Imaging (LDI) and indocyanine green dye (ICG) angiography in the prediction of burn scarring 28 days after injury using a previously validated porcine burn model that shows vertical progression injury. Twelve female Yorkshire swine were burned using a 2.5 × 2.5 cm metal bar at variable temperature and application times to create distinct burn depths. Six animals (48 injuries total) each were analyzed with LDI or ICG angiography at 1, 24, 48, and 72 h following injury. A linear regression was then performed correlating perfusion measurements against wound contraction at 28 days after injury. ICG angiography showed a peak linear correlate (r(2)) of .63 (95% CI .34 to .92) at 48 h after burn. This was significantly different from the LDI linear regression (p < .05), which was measured at r(2) of .20 (95% CI .02 to .39). ICG angiography linear regression was superior to LDI at all timepoints. Findings suggest that ICG angiography may have significant potential in the prediction of long-term burn outcomes.
Copyright © 2014 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Blood flow; Burns; Fluorescence; Indocyanine green; Scarring

Mesh:

Substances:

Year:  2014        PMID: 25499407     DOI: 10.1016/j.burns.2014.11.001

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  6 in total

1.  Quantitative Primary Tumor Indocyanine Green Measurements Predict Osteosarcoma Metastatic Lung Burden in a Mouse Model.

Authors:  Mitchell S Fourman; Adel Mahjoub; Jon B Mandell; Shibing Yu; Jessica C Tebbets; Jared A Crasto; Peter E Alexander; Kurt R Weiss
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

2.  An Inconvenient Truth of Clinical Assessment and Indocyanine Green Angiography Precise Marking for Indeterminate Burn Excision.

Authors:  Apinut Wongkietkachorn; Palakorn Surakunprapha; Kamonwan Jenwitheesuk; Kant Eua-Angkanakul; Kengkart Winaikosol; Pattama Punyavong; Nuttapone Wongkietkachorn; Supawich Wongkietkachorn; A Neil Salyapongse
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-03-24

Review 3.  Update on Osteosarcoma.

Authors:  Rebekah Belayneh; Mitchell S Fourman; Sumail Bhogal; Kurt R Weiss
Journal:  Curr Oncol Rep       Date:  2021-04-21       Impact factor: 5.075

4.  Indocyanine green dye angiography as an adjunct to assess indeterminate burn wounds: A prospective, multicentered, triple-blinded study.

Authors:  Apinut Wongkietkachorn; Palakorn Surakunprapha; Kengkart Winaikosol; Sakda Waraasawapati; Surachat Chaiwiriyakul; Kant Eua-Angkanakul; Nuttapone Wongkietkachorn; Pattama Punyavong; Kamonwan Jenwitheesuk; Bowornsilp Chowchuen
Journal:  J Trauma Acute Care Surg       Date:  2019-05       Impact factor: 3.313

5.  Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography Results in Negative Surgical Margins and Decreased Local Recurrence in an Orthotopic Mouse Model of Osteosarcoma.

Authors:  Adel Mahjoub; Alejandro Morales-Restrepo; Mitchell S Fourman; Jonathan B Mandell; Lu Feiqi; Margaret L Hankins; Rebecca J Watters; Kurt R Weiss
Journal:  Ann Surg Oncol       Date:  2018-12-27       Impact factor: 5.344

6.  Development of a Consistent and Reproducible Porcine Scald Burn Model.

Authors:  Christine J Andrews; Margit Kempf; Roy Kimble; Leila Cuttle
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.